How my CAR-T therapy research seeks to improve cancer care and empower nurses
Intended for healthcare professionals
Commentary Previous     Next

How my CAR-T therapy research seeks to improve cancer care and empower nurses

Emma Williams Haematology trials unit manager, Haematology clinical research group, University Hospital of Wales, Cardiff

Emma Williams’ research into CAR-T therapy for people with relapsed and refractory diffuse large B cell lymphoma hopes to improve knowledge of the cancer treatment and underline the importance of nurse research

No one could have prepared nurses for the widespread destruction that COVID-19 would have on our health organisations with our whole way of working literally changing overnight.

Nurse Researcher. 30, 2, 6-7. doi: 10.7748/nr.30.2.6.s2

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more